Cholera toxin indirectly activates human monocyte-derived dendritic cells in vitro through the production of soluble factors, including prostaglandin E2 and nitric oxide

Clinical and Vaccine Immunology

Volumn 13, Issue 1, 2006, Pages 106-115

  Bagley, Kenneth C ^a,b   Abdelwahab, Saved F ^a,c   Tuskan, Robert G ^a   Lewis, George K ^a  

^a UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c MINIA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; ACETYLSALICYLIC ACID; ARISTOLOCHIC ACID; BROMOENOL LACTONE; BUCLADESINE; CHEMOKINE RECEPTOR CCR7; CHOLERA TOXIN; CYCLIC AMP; GUANYLATE CYCLASE; IMMUNOLOGICAL ADJUVANT; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NITRIC OXIDE; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BYSTANDER EFFECT; CELL ACTIVATION; CELL MATURATION; CELL MIGRATION; CONTROLLED STUDY; DENDRITIC CELL; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MIXED CELL CULTURE; MIXED LYMPHOCYTE REACTION; MONOCYTE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; VIBRIO CHOLERAE;

BYSTANDER EFFECT; CELLS, CULTURED; CHOLERA TOXIN; DENDRITIC CELLS; DINOPROSTONE; HUMANS; MONOCYTES; NITRIC OXIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33645131798     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.13.1.106-115.2006     Document Type: Article

References (51)

1. Akaike, T., M. Yoshida, Y. Miyamoto, K. Sato, M. Kohno, K. Sasamoto, K. Miyazaki, S. Ueda, and H. Maeda. 1993. Antagonistic action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor/.NO through a radical reaction. Biochemistry 32:827-832.
2. Bagley, K. C., S. F. Abdelwahab, R. G. Tuskan, T. R. Fouts, and G. K. Lewis. 2002. Cholera toxin and heat-labile enterotoxin activate human monocyte-derived dendritic cells and dominantly inhibit cytokine production through a cyclic AMP-dependent pathway. Infect. Immun. 70:5533-5539.
3. Bagley, K. C., S. F. Abdelwahab, R. G. Tuskan, T. R. Fouts, and G. K. Lewis. 2002. Pertussis toxin and the adenylate cyclase toxin from Bordetella pertussis activate human monocyte-derived dendritic cells and dominantly inhibit cytokine production through a cAMP-dependent pathway. J. Leukoc. Biol. 72:962-969.
4. Bagley, K. C., S. F. Abdelwahab, R. G. Tuskan, and G. K. Lewis. 2004. Calcium signaling through phospholipase C activates dendritic cells to mature and is necessary for the activation and maturation of dendritic cells induced by diverse agonists. Clin. Diagn. Lab. Immunol. 11:77-82.
5. Bagley, K. C., S. F. Abdelwahab, R. G. Tuskan, and G. K. Lewis. 2003. An enzymatically active A domain is required for cholera-like enterotoxins to induce a long-lived blockade on the induction of oral tolerance: new method for screening mucosal adjuvants. Infect. Immun. 71:6850-6856.
6. Bagley, K. C., M. T. Shata, D. Y. Onyabe, A. L. DeVico, T. R. Fouts, G. K. Lewis, and D. M. Hone. 2003. Immunogenicity of DNA vaccines that direct the coincident expression of the 120 kDa glycoprotein of human immunodeficiency virus and the catalytic domain of cholera toxin. Vaccine 21:3335-3341.
7. Beubler, E., G. Kollar, A. Sana, K. Bukhave, and J. Rask-Madsen. 1989. Involvement of 5-hydroxytryptamine, prostaglandin E2, and cyclic adenosine monophosphate in cholera toxin-induced fluid secretion in the small intestine of the rat in vivo. Gastroenterology 96:368-376.
8. Beubler, E., R. Schuligoi, A. K. Chopra, D. A. Ribardo, and B. A. Peskar. 2001. Cholera toxin induces prostaglandin synthesis via post-transcriptional activation of cyclooxygenase-2 in the rat jejunum. J. Pharmacol. Exp. Ther. 297:940-945.
9. Billiar, T. R., R. D. Curran, D. J. Stuehr, M. A. West, B. G. Bentz, and R. L. Simmons. 1989. An L-arginine-dependent mechanism mediates Kupffer cell inhibition of hepatocyte protein synthesis in vitro. J. Exp. Med. 169:1467-1472.
10. Brunner, F., H. Stessel, and W. R. Kukovetz. 1995. Novel guanylyl cyclase inhibitor, ODQ reveals role of nitric oxide, but not of cyclic GMP in endothelin-1 secretion. FEBS Lett. 376:262-266.
11. Burch, R. M., C. Jelsema, and J. Axelrod. 1988. Cholera toxin and pertussis toxin stimulate prostaglandin E2 synthesis in a murine macrophage cell line. J. Pharmacol. Exp. Ther. 244:765-773.
12. Cassel, D., and Z. Selinger. 1977. Mechanism of adenylate cyclase activation by cholera toxin: inhibition of GTP hydrolysis at the regulatory site. Proc. Natl. Acad. Sci. USA 74:3307-3311.
13. Chen, C. C., K. T. Chiu, Y. T. Sun, and W. C. Chen. 1999. Role of the cyclic AMP-protein kinase A pathway in lipopolysaccharide-induced nitric oxide synthase expression in RAW 264.7 macrophages. Involvement of cyclooxygenase-2. J. Biol. Chem. 274:31559-31564.
14. Dauer, M., B. Obermaier, J. Berten, C. Haerle, K. Pohl, S. Rothenfusser, M. Schnurr, S. Endres, and A. Eigler. 2003. Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors. J. Immunol. 170:4069-4076.
15. Denninger, J. W., and M. A. Marietta. 1999. Guanylate cyclase and the NO/cGMP signaling pathway. Biochim. Biophys. Acta 1411:334-350.
16. Dieu, M. C., B. Vanbervliet, A. Vicari, J. M. Bridon, E. Oldham, S. Ait-Yahia, F. Briere, A. Zlotnik, S. Lebecque, and C. Caux. 1998. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 188:373-386.
17. Dieu-Nosjean, M. C., A. Vicari, S. Lebecque, and C. Caux. 1999. Regulation of dendritic cell trafficking: a process that involves the participation of selective chemokines. J. Leukoc. Biol. 66:252-262.
18. Fogel-Petrovic, M., J. A. Long, D. A. Knight, P. J. Thompson, and J. W. Upham. 2004. Activated human dendritic cells express inducible cyclo-oxygenase and synthesize prostaglandin E2 but not prostaglandin D2. Immunol. Cell Biol. 82:47-54.
19. Forster, R., A. Schubel, D. Breitfeld, E. Kremmer, I. Renner-Muller, E. Wolf, and M. Lipp. 1999. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99:23-33.
20. Futaki, N., S. Takahashi, M. Yokoyama, I. Arai, S. Higuchi, and S. Otomo. 1994. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 47:55-59.
21. Gagliardi, M. C., F. Sallusto, M. Marinaro, A. Langenkamp, A. Lanzavecchia, and M. T. De Magistris. 2000. Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming. Eur. J. Immunol. 30:2394-2403.
22. Gilroy, D. W., A. Tomlinson, and D. A. Willoughby. 1998. Differential effects of inhibition of isoforms of cyclooxygenase (COX-1, COX-2) in chronic inflammation. Inflamm. Res. 47:79-85.
23. Giuliani, M. M., G. Del Giudice, V. Giannelli, G. Dougan, G. Douce, R. Rappuoli, and M. Pizza. 1998. Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity. J. Exp. Med. 187:1123-1132.
24. Grider, J. R. 1993. Interplay of VIP and nitric oxide in regulation of the descending relaxation phase of peristalsis. Am. J. Physiol. 264:G334-G340.
25. Havenga, M. J., B. van Dam, B. S. Groot, J. M. Grimbergen, D. Valerie, A. Bout, and P. H. Quax. 2001. Simultaneous detection of NOS-3 protein expression and nitric oxide production using a flow cytometer. Anal. Biochem. 290:283-291.
26. Hazen, S. L., L. A. Zupan, R. H. Weiss, D. P. Getman, and R. W. Gross. 1991. Suicide inhibition of canine myocardial cytosolic calcium-independent phospholipase A2. Mechanism-based discrimination between calcium-dependent and -independent phospholipases A2. J. Biol. Chem. 266:7227-7232.
27. Hazes, B., and R. J. Read. 1997. Accumulating evidence suggests that several AB-toxins subvert the endoplasmic reticulum-associated protein degradation pathway to enter target cells. Biochemistry 36:11051-11054.
28. Heyningen, S. V. 1974. Cholera toxin: interaction of subunits with ganglioside GM1. Science 183:656-657.
29. Kantengwa, S., L. Jornot, C. Devenoges, and L. P. Nicod. 2003. Superoxide anions induce the maturation of human dendritic cells. Am. J. Respir. Crit. Care Med. 167:431-437.
30. Ko, F. N., C. C. Wu, S. C. Kuo, F. Y. Lee, and C. M. Teng. 1994. YC-1, a novel activator of platelet guanylate cyclase. Blood 84:4226-4233.
31. Kojima, H., K. Sakurai, K. Kikuchi, S. Kawahara, Y. Kirino, H. Nagoshi, Y. Hirata, and T. Nagano. 1998. Development of a fluorescent indicator for nitric oxide based on the fluorescein chromophore. Chem. Pharm. Bull. (Tokyo) 46:373-375.
32. Laneuville, O., D. K. Breuer, D. L. Dewitt, T. Hla, C. D. Funk, and W. L. Smith. 1994. Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs. J. Pharmacol. Exp. Ther. 271:927-934.
33. Lowenstein, C. J., C. S. Glatt, D. S. Bredt, and S. H. Snyder. 1992. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc. Natl. Acad. Sci. USA 89:6711-6715.
34. Lycke, N. 2004. From toxin to adjuvant: the rational design of a vaccine adjuvant vector, CTA1-DD/ISCOM. Cell. Microbiol. 6:23-32.
35. Lycke, N. 1997. The mechanism of cholera toxin adjuvanticity. Res. Immunol. 148:504-520.
36. Lycke, N., and J. Holmgren. 1987. Long-term cholera antitoxin memory in the gut can be triggered to antibody formation associated with protection within hours of an oral challenge immunization. Scand. J. Immunol. 25:407-412.
37. Lycke, N., T. Tsuji, and J. Holmgren. 1992. The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity. Eur. J. Immunol. 22:2277-2281.
38. Morelli, A. E., and A. W. Thomson. 2003. Dendritic cells under the spell of prostaglandins. Trends Immunol. 24:108-111.
39. Norgauer, J., Y. Ibig, D. Gmeiner, Y. Herouy, and B. L. Fiebich. 2003. Prostaglandin E2 synthesis in human monocyte-derived dendritic cells. Int. J. Mol. Med. 12:83-86.
40. Ohtomo, N., T. Muraoka, A. Tashiro, Y. Zinnaka, and K. Amako. 1976. Size and structure of the cholera toxin molecule and its subunits. J. Infect. Dis. 133(Suppl.):31-40.
41. Paolucci, C., S. E. Burastero, P. Rovere-Querini, C. De Palma, S. Falcone, C. Perrotta, A. Capobianco, A. A. Manfredi, and E. Clementi. 2003. Synergism of nitric oxide and maturation signals on human dendritic cells occurs through a cyclic GMP-dependent pathway. J. Leukoc. Biol. 73:253-262.
42. Rieser, C., G. Bock, H. Klocker, G. Bartsch, and M. Thurnher. 1997. Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production. J. Exp. Med. 186:1603-1608.
43. Roederer, M., F. J. Staal, P. A. Raju, S. W. Ela, and L. A. Herzenberg. 1990. Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. Proc. Natl. Acad. Sci. USA 87:4884-4888.
44. Rosenthal, M. D., B. S. Vishwanath, and R. C. Franson. 1989. Effects of aristolochic acid on phospholipase A2 activity and arachidonate metabolism of human neutrophils. Biochim. Biophys. Acta 1001:1-8.
45. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1109-1118.
46. Scandella, E., Y. Men, D. F. Legler, S. Gillessen, L. Prikler, B. Ludewig, and M. Groettrup. 2004. CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2. Blood 103:1595-1601.
47. Sporri, R., and C. Reis e Sousa. 2005. Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function. Nat. Immunol. 6:163-170.
48. Vajdy, M., and N. Y. Lycke. 1992. Cholera toxin adjuvant promotes long-term immunological memory in the gut mucosa to unrelated immunogens after oral immunization. Immunology 75:488-492.
49. Verhasselt, V., W. Vanden Berghe, N. Vanderheyde, F. Willems, G. Haegeman, and M. Goldman. 1999. N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF-kappaB inhibition. J. Immunol. 162:2569-2574.
50. Whittaker, D. S., K. S. Bahjat, L. L. Moldawer, and M. J. Clare-Salzler. 2000. Autoregulation of human monocyte-derived dendritic cell maturation and IL-12 production by cyclooxygenase-2-mediated prostanoid production. J. Immunol. 165:4298-4304.
51. Woodward, D. F., D. J. Pepperl, T. H. Burkey, and J. W. Regan. 1995. 6-Isopropoxy-9-oxoxanthene-2-carboxylic acid (AH 6809), a human EP2 receptor antagonist. Biochem. Pharmacol. 50:1731-1733.